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In Hermansky–Pudlak Syndrome (HPS) a mutation in a
79.3 kDa transmembrane protein has been shown. The
function of this protein has escaped definition so far.
This study unveils a defective (6R)-L-erythro-5,6,7,8-
tetrahydrobiopterin (6BH4) de novo synthesis/recycling
for this cofactor in HPS, where activities of the key
enzyme GTP-cyclohydrolase I are in the normal range,
but total biopterin levels are significantly decreased in
homozygotes (n J 5) compared with unaffected controls
(n J 4) (p J 0.00001). Phenylalanine hydroxylase and
4a-hydroxy-6BH4-dehydratase activities are significantly
lower. mRNA of all enzymes involved in 6BH4 biosyn-
thesis/recycling and GTP-cyclohydrolase I feedback
regulatory protein were expressed in keratinocytes from
homozygotes, heterozygotes, and healthy controls.
Thioredoxin/thioredoxin reductase can directly control
the redox status of 6BH4. These activities are allosterically
controlled by calcium. Therefore calcium would directly
Hermansky–Pudlak Syndrome (HPS) is an autosomalrecessive inherited disease characterized by the triadof a tyrosinase positive oculocutaneous albinism, amild bleeding diathesis due to a storage pool deficiencyand an accumulation of ceroid-like material in
reticuloendothelial cells and tissues (Hermansky and Pudlak, 1959;
Witkop et al, 1974). The bleeding disorder is associated with decreased
numbers of platelet dense bodies concomitant with a decrease of 5-
hydroxy-tryptamine, nonmetabolic adenosine diphosphate, and calcium
in these organelles (Hardisty and Hutton, 1967; Logan et al, 1971;
Hardisty et al, 1972; Maurer et al, 1972; Weiss et al, 1974; Nagayama
et al, 1987; Fuse et al, 1992). An impaired calcium homeostasis was
observed in epidermal keratinocytes of HPS homozygotes (Schallreuter
and Pittelkow, 1989). In addition, elevated dolichol excretion in urine
has been described in the affected Puerto Rican population (Witkop
et al, 1987).
Recently, homozygous frameshift mutations in a novel transmem-
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affect this redox status. In HPS these enzyme activities
are low concomitant with a defective calcium uptake,
suggesting an extracellular accumulation of this second
messenger. In this context phenylalanine hydroxylase
is subject to phosphorylation/activation by calcium/
calmodulin activated kinases. Therefore it was anticipated
that calcium could directly affect the cellular L-phenylal-
anine turnover to L-tyrosine. A significantly more rapid
L-phenylalanine uptake and its turnover to L-tyrosine
was identified in normal human melanocytes (n J 5)
and keratinocytes (n J 2), and was more enhanced in
melanocytes in the presence of 2 H 10–3 M calcium. The
turnover to L-tyrosine was significantly slower. Based on
all evidence to date, we speculate that the mutated protein
in HPS could be primarily involved in maintaining
calcium homeostasis in this patient group. Key words:
HPS/pigmentation/pterins. J Invest Dermatol 111:511–516,
1998
brane protein were described in four HPS populations, i.e., Puerto
Rico, Switzerland, Japan, and Ireland (Oh et al, 1996). It has been
suggested that this protein may control the development of several
cytoplasmic organelles (Oh et al, 1996); however, at the present time,
the true function of this protein remains to be elucidated. This
single gene defect must account for variable clinical and phenotypical
expression such as oculocutaneous albinism, a storage pool deficiency
with decreased numbers of dense bodies in platelets, a ceroid/lipofuscin-
like accumulation in various cells and tissues (Witkop et al, 1990),
normal numbers of melanocytes with abnormal melanosomes con-
taining tyrosinase (Kugelman and Scott, 1961; Frenk and Lattion,
1982), a defective antioxidant status (Schallreuter and Witkop, 1988;
Wolfe et al, 1981; Schallreuter and Wood, 1989a; Schallreuter et al,
1993), an altered calcium homeostasis in platelets and keratinocytes
(Nagayama et al, 1987; Schallreuter and Pittelkow, 1989), an impaired
5-hydroxy-tryptamine transport together with a reduction of the
nonmetabolic adenosine diphosphate-pool in platelets (Gerritson et al,
1977; Fuse et al, 1992), and an increase of nonmelanoma skin cancer.1
The clinical skin and hair phenotypes of HPS homozygotes can vary
from totally white skin/hair to normal pigmentation. Homozygotes
have epidermal melanocytes and express tyrosinase activities in their
hairbulb melanocytes (Kugelman and Scott, 1961; Frenk and Lattion,
1982; King and Olds, 1985), but only rarely exhibit full melanogenesis.
It was demonstrated that the L-tyrosine supply can be altered in
epidermal cells of the depigmentation disorder vitiligo by a defective
1Schallreuter KU, Witkop Jr CJ: unpublished results.
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Figure 1. The key enzyme for de novo synthesis of 6BH4, GTP-CH-I,
uses GTP to form dihydroneopterin triphosphate followed by the
conversion to sepiapterin by PTPS. Sepiapterin is metabolised by SR to
6BH4. 6BH4 serves as a cofactor for PAH to form L-tyrosine from the essential
amino acid L-phenylalanine in the presence of O2. The recycling of the cofactor
produces 4a-hydroxy-tetrahydrobiopterin, and nonenzymatically 7BH4, the
isomer of 6BH4. 4a-hydroxy-tetrahydrobiopterin is metabolised by DH to
quinonoid dihydropterin (qBH2) and then finally reduced back to 6BH4 by
dihydropteridine reductase in the presence of NADH. GFRP controls the de
novo synthesis, where L-phenylalanine upregulates GTP-CH-I activities, whereas
6BH4 exerts the opposite effect.
de novo synthesis/recycling process of the cofactor (6R)-L-erythro-
5,6,7,8-tetrahydrobiopterin (6BH4) (Schallreuter et al, 1994a, b). This
cofactor drives the metabolism from the essential amino acid L-
phenylalanine to L-tyrosine via phenylalanine hydroxylase (PAH) and
from tryptophan to 5-hydroxytryptamine via tryptophan monooxygen-
ase and tyrosine hydroxylase (TH), the key enzyme for catecholamine
biosynthesis (Nichol et al, 1985).
Epidermal melanocytes and keratinocytes hold the full capacity for
de novo synthesis/recycling of 6BH4 (Schallreuter et al, 1994a, b), where
GTP-cyclohydrolase I (GTP-CH-I) is the rate limiting enzyme for de
novo synthesis and 4a-hydroxy-6BH4-dehydratase (DH) controls the
recycling process by coupling to PAH (Nichol et al, 1985; Davis
and Kaufman, 1989). The de novo synthesis is controlled by GTP-
cyclohydrolase I feedback regulatory protein (GFRP) (Harada et al,
1993) (Fig 1).
The important role of 6BH4 in de novo melanogenesis of different
skin types has been realised, where the induction of GTP-CH-I by
tumor necrosis factor alpha (TNFα), PAH, DH, and 6BH4 followed
UVB radiation after application of only one individual minimal
erythema dose (Schallreuter et al, 1997). One consequence of this
induction is a rise in epidermal L-tyrosine concentration. This increase
of L-tyrosine levels has been identified in vivo using noninvasive
Fourier-Transform Raman spectroscopy.2 It should be taken into
consideration that HPS homozygotes have melanocytes, and their
tyrosinase activity can be demonstrated in hairbulbs in the presence of
sufficient concentrations of L-tyrosine (Witkop et al, 1990). We
therefore aimed to follow epidermal 6BH4 de novo synthesis/recycling
and the cellular uptake of L-phenylalanine and its’ turnover to L-
tyrosine in the presence and absence of calcium in the Puerto Rican
patient group, where this albinism presents the most common single
gene disorder in 1–1800 persons (Oh et al, 1996).
MATERIALS AND METHODS
Patients and probands A written consent was obtained prior to this study
from each participant or from his/her parents. Nineteen members of Puerto
Rican HPS kindreds served for this project. The HPS homozygotes (n 5 8)
were classified previously (Schallreuter and Witkop, 1988). Four individuals were
2Schallreuter KU, Zschiesche M, Moore J, et al: Evidence for compromised
phenylalanine hydroxylase activity in vitiligo. Pigment Cell Res 10:357, 1997
(abstr.)
Table I. Epidemiologic characteristics of patients and
probands
Number Sex Age Probands Skin types
(Fitzpatrick classification)
1 M 49 HPS homozygote White/freckles
2 F 44 HPS homozygote White/freckles
3 F 26 HPS homozygote White
4 F 34 HPS homozygote White/freckles
5 F 15 HPS homozygote White
6 M 18 HPS homozygote White/freckles
7 M 40 HPS homozygote White/freckles
8 M 22 HPS homozygote White
9 F 69 Obligate heterozygote IV
10 M 40 Obligate heterozygote V
11 F 37 Obligate heterozygote V
12 F 36 Obligate heterozygote V
13 F 45 Unaffected III
14 F 18 Unaffected IV
15 F 17 Unaffected IV
16 M 38 Unaffected IV
17 F 37 Unaffected III
18 M 15 Unaffected V
19 M 21 Unaffected V
obligate heterozygotes and seven probands were clinically and phenotypically
unremarkable. None of the probands were on any medication at the time point
of examination. Table I summarizes the patients/probands characteristics.
Epidermal cell extracts Epidermal suction blister roofs were obtained and
prepared as described previously (Schallreuter et al, 1994b). Protein content of
each cell extract was determined using the method of Kalb and Bernlohr (1977).
Cell cultures of epidermal keratinocytes and melanocytes Keratinocytes
and melanocytes were established from epidermal suction blister roofs from
HPS homozygotes (n 5 4), one obligate heterozygote, one uncharacterized
family member, and four normal controls. Keratinocytes were cultured by the
method of Wille et al (1984). Melanocytes were established following the
method of Pittelkow et al (1989). Pigmentation was followed upon the addition
of L-tyrosine (10–6 M) to the culture medium over time (day 0 to day 8).
Determination of total epidermal biopterins by high performance liquid
chromatography Biopterins were analyzed after acidic iodine oxidation and
prepurification by cation exchange chromatography using DOWEX AG 50
(Wx8) followed by reverse phase high performance liquid chromatography and
fluorimetric detection as previously described (Kerler et al, 1990; Ziegler and
Hu¨ltner, 1992). Biopterin levels were determined as pM per mg protein.
Enzyme assays GTP-CH-I was determined by reverse phase high perform-
ance liquid chromatography following the formation of neopterin with alkaline
phosphatase using previously published methods (Blau and Niederwieser, 1983;
Kerler et al, 1990). Specific activity of GTP-CH-I was defined as pM neopterin
mg per protein per h.
PAH activity was evaluated following the formation of 14C-labeled tyrosine
from [14C]L-phenylalanine, using the method of Schallreuter et al (1994a, b).
Activities were determined in nM per mg protein per min.
DH activities were assessed as previously described (Schallreuter et al, 1994a,
b). Enzyme activities were determined in nM per mg protein per min.
Expression of epidermal mRNA from undifferentiated keratinocytes in
HPS and controls using reverse transcriptase-polymerase chain reaction
(PCR) Total RNA was extracted from undifferentiated keratinocytes of HPS
patients (n 5 4), one normal heterozygote normal neonatal foreskin (n 5 2),
and adult skin (n 5 2) using Ambion Totally RNA Isolation Kit (AMS
Biotechnology, Oxon, U.K.), and subjected to reverse transcriptase-PCR
analysis as described previously (Schallreuter et al, 1998). Primers and conditions
for the PCR reactions were as described below. PCR products were separated
on a 1.5% agarose gel. All primers were designed based upon the cDNA
sequence from Genebank acquisition numbers:
GTP-CH-I (U19523) 59CCTGAACGAGCACAGAATGA39 and 59ATCAAA-
GTGGCAGAGATGGG39. PCR conditions were 35 cycles at 92°C 19, 60°C
19, and 72°C 19.
GFRP (U71890) 59GACAGGCACAGAGAGAAAG39 and 59TGAGAGGAG-
GAATGGAAG39. PCR conditions were 40 cycles at 95°C 19, 55°C 19, and
72°C 19.
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PAH (K03020) 59TTGCTGACATTGCCTACAAC39 and 59ACCCAAG-
AAATCCCGAGAG39. PCR conditions were 45 cycles at 95°C 19, 55°C 19,
and 72°C 19.
DH (L41559) 59GCCATCTTCAAGCAGTTTC39 and 59AGCTTCAGT-
CACCCTTTCC39. PCR conditions were 35 cycles at 92°C 19, 55°C 19, and
72°C 19.
TR (G29720) 59ACATGGAAGAACATGGCA39 and 59CTCCTCAGAAAG-
GCCACAAG39. PCR conditions were 35 cycles at 92°C 19, 60°C 19, and
72°C 19.
Thioredoxin (J04026) 59TTTCCATCGGTCCTTACAGC39 and 59TTGGCT-
CCAGAAAATTCACC39. PCR conditions were 35 cycles at 35°C 19, 60°C
19, and 72°C 19.
Uptake of [14C]L-phenylalanine and its turnover in human melanocytes
and keratinocytes The uptake of [14C]L-phenylalanine and its metabolism
to [14C]L-tyrosine was followed over 20 min in intact confluent monolayers
of human melanocytes (n 5 5), undifferentiated keratinocytes (n 5 2), and
differentiated keratinocytes (n 5 2). In order to study the effect of calcium on
the L-phenylalanine uptake and its turnover, melanocytes were exposed to
2 3 10–3 M calcium in the medium for 24 h. The concentrations of
both amino acids were determined after separation by cellulose thin layer
chromatography and counting in the 14C channel of a Beckman Scintillation
counter (Schallreuter et al, 1994b)
Uptake of [3H]L-tyrosine in human melanocytes The uptake of [3H]L-
tyrosine was followed over 20 min in intact monolayers of human melanocytes
(n 5 5). The possible effect of 2 3 10–3 M calcium on the L-tyrosine uptake
was in studied melanocytes only. The final concentration of the amino acid
was measured in the 3H channel as above. For final calculation the activity was
correlated to mg protein (Schallreuter and Pittelkow, 1989).
Statistical analysis The data were analyzed by the standard paired Student
t test from the mean values.
Chemicals 6BH4, 7BH4, 6-biopterin, and 7-biopterin were from Dr.
B. Schircks, (Jona, Switzerland). L-[14CU]-phenylalanine (513 mCi per mM)
and L-[3.5 3H]-tyrosine (47 Ci per mM) were obtained from Amersham Life
Sciences (Bucks, U.K.). Phenylalanine hydroxylase, catalase, and all other
reagents were from Sigma (Poole, Dorset, U.K.).
RESULTS
Epidermal GFRP and GTP-CH-I mRNA expression, and nor-
mal enzyme activites in HPS GTP-CH-I represents the key
enzyme for de novo synthesis of the cofactor 6BH4 (Nichol et al, 1985).
Messenger RNA was expressed in undifferentiated keratinocytes from
homozygotes (n 5 4), one obligate heterozygote and two controls.
Determination of epidermal GTP-CH-I specific activities in patients
with HPS (n 5 5), obligate heterozygotes (n 5 3), and controls (n 5
3) showed no significant difference between these three groups ranging
from 1.6 to 2.1 pM per mg protein per h. Analysis of the mRNA for
GFRP showed a weak expression for homozygotes (n 5 4), the
uncharacterized family member as well as in one obligate heterozygote
compared with controls.
Decreased 6-biopterin levels in the epidermis of HPS
Evaluation of total biopterins from epidermal suction blister cell extracts
demonstrated significantly lower levels of total 6-biopterin (i.e., 6BH4
plus 6-biopterin) with unaffected 7-biopterin levels in HPS homozy-
gotes (n 5 5) compared with heterozygotes (n 5 3) and controls (n 5
4) (Fig 2). Because GTP-CH-I activities are normal and 6BH4 levels
are low in homozygotes, we examined mRNA expression of 6-
pyruvoyl-tetrahydropterin-synthase (PTPS) and sepiapterin reductase
(SR), the enzymes catalyzing the second and third intermediary steps
between GTP-CH-I and 6BH4 formation (Fig 1). Both enzymes are
expressed in HPS homozygotes, heterozygotes, and controls.
Low epidermal PAH and DH activities in HPS Determination
of PAH activities in epidermal cell extracts from HPS homozygotes
(n 5 8) were significantly lower compared with heterozygotes (n 5
4) and controls (n 5 7), whereas mRNA expression appeared to be
unaffected (Fig 3A, B). Significantly lower DH activities were also
found in HPS homozygotes (n 5 8), whereas enzyme activities
were normal in obligate heterozygotes and controls (Fig 4). mRNA
expression for DH showed no differences compared with controls.
Figure 2. Total 6- and 7-biopterin levels in HPS homozygotes (n J 5),
obligate heterozygotes (n J 3), and controls (n J 3). The 6-biopterin
levels are significantly lower in homozygotes compared with heterozygotes and
controls (p 5 0.00001), whereas 7-biopterin levels are in the physiologic range.
Mean 6SD.
Because the redox status of the pterins can be controlled by the
thioredoxin/thioredoxin reductase system and the activities of this
important antioxidant mechanism are low in HPS homozygotes, we
followed the expression of thioredoxin/thioredoxin reductase mRNA
(Schallreuter and Witkop, 1988; Schallreuter et al, 1993, 1994c). There
were no differences between homozygotes, heterozygotes, and controls.
Successful pigmentation of HPS melanocytes in vitro One
consequence of decreased epidermal PAH activity is a decrease in L-
tyrosine formation from the essential amino acid L-phenylalanine in
the presence of 6BH4. HPS is a tyrosinase positive albinism with
different phenotypical expression and tyrosinase activities in hairbulbs
from homozygotes (Kugelman and Scott, 1961). Consequently, we
established melanocytes from two HPS homozygotes (clinically white
with freckles on the arms and dorsum of the hands) to follow
pigmentation under in vitro conditions in the presence of L-tyrosine
(10–6 M) from day 0 to day 8. Under these conditions, melanin
production started at day 2 (Fig 5).
The importance of L-phenylalanine uptake and intracellular
tyrosine formation versus L-tyrosine uptake in melanocytes
compared with keratinocytes It is noteworthy that pigmentation
requires 10–6 M L-tyrosine (Prota, 1992). Therefore the question arises;
where does the intracellular tyrosine originate? Figure 6 demonstrates
a rapid uptake of [14C]L-phenylalanine and its intracellular turnover
to [14C]L-tyrosine in human normal melanocytes (n 5 5) over 20 min
in the presence of 0.2 and 2.0 3 10–3 M calcium. The results clearly
show a significantly faster uptake of L-phenylalanine in the presence
of 2 3 10–3 M calcium, whereas the turnover to L-tyrosine is slowed
down. In order to compare this specific L-phenylalanine uptake and
turnover with the direct L-tyrosine uptake, the experiment was repeated
in the presence of [3H]L-tyrosine. The [3H]L-tyrosine uptake is not
affected by calcium. Unfortunately we did not have sufficient numbers
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Figure 3. PAH activities and mRNA expression in HPS patients
compared with healthy controls. (A) PAH activities (nM per mg protein
per min) in HPS homozygotes (n 5 8), obligate heterozygotes (n 5 4), and
controls (n 5 7). There is significantly lower activity in HPS homozygotes
(p 5 0.0001) supporting a shortage in intracellular L-tyrosine supply. (B)
Reverse transcriptase-PCR of PAH mRNA expression standardized to beta
actin. The order of samples on the gel is from left to right: negative control,
unrelated healthy control (n 5 2), uncharacterized family member (n 5 1),
homozygote (n 5 4), obligate heterozygote (n 5 1).
of melanocytes to repeat this experiment with HPS cells. Figure 6
illustrates a representative experiment of the L-tyrosine uptake, L-
phenylalanine uptake, and its turnover to L-tyrosine. These kinetic
analyses identify active transport for L-phenylalanine, whereas L-
tyrosine shows facilitated diffusion.
DISCUSSION
A linkage analysis of the Puerto Rican HPS population mapped this
syndrome on chromosome 10q23 and the HPS gene was cloned
followed by cDNA sequence analysis (Oh et al, 1996). The HPS gene
has 20 exons coding for a 79.3 kDa protein. At the present time this
protein has no reported sequence homology and its’ function is
Figures 4. DH activities (nM per mg protein per min) in HPS
homozygotes (n J 8), obligate heterozygotes (n J 4), and controls
(n J 7). The results show significantly lower DH activities in HPS homozygotes
(p 5 0.0001). Mean 6 SD.
Figure 5. Epidermal melanocytes (passage 3) from one HPS homozygote
in the presence of 10–6 M L-tyrosine show a clear formation of melanin
in all cells under in vitro conditions (after 6 d in culture). Scale bar: 50 µm.
unknown (Oh et al, 1996). Accordingly, all of the Puerto Rican
patients studied so far were homozygous for a 16 base pair duplication
in exon 15 indicative of a founder effect. Different mutations in the
HPS gene were detected in Swiss, Irish, and Japanese probands with
this disorder (Oh et al, 1996). Puerto Rican HPS patients express
different phenotypes with regard to skin and hair pigmentation
(Schallreuter and Witkop, 1988). This result could point to a possible
regulation of pigmentation by the HPS protein rather than a direct
effect on tyrosinase.
Our report shows that HPS melanocytes have the capacity in vitro
to synthesize melanin in the presence of sufficient L-tyrosine concentra-
tions. Because both melanocytes and keratinocytes have the full capacity
to synthesize and recycle 6BH4 for their individual synthesis of L-
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Figure 6. L-phenylalanine uptake and metabolism in normal human
melanocytes and keratinocytes. (A) A comparative study of [14C]L-
phenylalanine uptake and metabolism to [14C]L-tyrosine over 20 min in normal
human melanocytes (n 5 5) and keratinocytes (n 5 2) in the presence of
0.2 3 10–3 M and 2 3 10–3 M calcium in the culture medium; (B) [14C]L-
phenylalanine active transport kinetics in normal human melanocytes in the
presence of 0.2 3 10–3 M calcium and conversion to [14C]L-tyrosine compared
with [3H]L-tyrosine facilitated diffusion under standardized experimental
conditions. For each experiment, 130 µM amino acid was added to the culture
medium and the time course for uptake was followed over 20 min.
tyrosine from the essential amino acid L-phenylalanine (Schallreuter
et al, 1994a, b), it is noteworthy that these cells do not depend on an
extracellular L-tyrosine supply, as suggested recently (Baillin et al, 1997;
Feng et al, 1997). Our new data on L-phenylalanine uptake in intact
monolayers of healthy melanocytes clearly show a preferential transport
of L-phenylalanine over L-tyrosine. These cells can acquire L-tyrosine
as demonstrated in the induced pigmentation of HPS melanocytes,
and in the [3H]L-tyrosine uptake studies, although this process is much
slower (Fig 6B). Our results also indicate that HPS homozygotes are
deficient in both the de novo synthesis and the recycling of 6BH4, a
result that could explain the low availability of L-tyrosine for melanin
synthesis in the majority of HPS homozygotes.
Total biopterin levels are significantly reduced even though GTP-
CH-I is expressed and activities are normal in these patients; however,
low 6BH4 levels could also be the result of impaired PTPS and/or SR
activities, enzymes catalysing the intermediate steps between GTP-
CH-I and 6BH4 synthesis (Fig 1). Both PTPS and SR mRNA were
expressed in all samples, but enzyme activities remain to be determined.
In the recycling process of 6BH4, both PAH and DH mRNA are
expressed, although activities were reduced in HPS homozygotes.
Analyses of the mRNA expression of thioredoxin/thioredoxin reduc-
tase is unremarkable in HPS, despite the significantly reduced activities
of membrane-associated TR in homozygotes in the Puerto Rican and
Swiss populations (Schallreuter and Witkop, 1988; Schallreuter et al,
1993). It is noteworthy that the decrease in the activities of this
important antioxidant enzyme was more pronounced in the Puerto
Rican compared with the Swiss population, which could account for
the clinically different expression of the disease and the different
mutations reported in these two locations (Schallreuter and Witkop,
1988; Schallreuter et al, 1993; Oh et al, 1996).
How can the perturbations in 6BH4 synthesis/recycling, together
with TR-mediated decreased antioxidant status in membranes and an
impaired calcium homeostasis, be reconciled in terms of the recently
established mutations in the HPS protein? To date there are six major
clues in support of a perturbed calcium homeostasis:
1 Calcium is an important constituent of platelet dense bodies.
Its uptake/efflux is impaired in keratinocytes from HPS individuals
compared with controls as well as in their platelets (Schallreuter and
Pittelkow, 1989).
2 Calcium influences the uptake of the essential amino acid L-
phenylalanine in normal human melanocytes and keratinocytes, whereas
L-tyrosine uptake is unaffected.
3 Calcium decreased the intracellular L-phenylalanine turnover to L-
tyrosine in normal human melanocytes.
4 PTPS, SR, and the coupled PAH/DH systems are activated by
phosphorylation involving Ca21/calmodulin dependent kinases. SR as
well as the important 6BH4 recycling enzyme dihydropteridine reduc-
tase, are inactivated by calcium activated neutral proteases (Katch et al,
1994, 1997; Tho¨ny et al, 1997).
5 TR is downregulated allosterically by calcium binding to a single
EF-hands regulatory domain. It could be possible that the reduced TR
activities in HPS homozygotes are caused by a direct calcium inhibition
of this enzyme (Schallreuter and Wood, 1989b).
6 The formation of ceroid/lipofuscin like material in HPS homozygotes
from Puerto Rico has been linked to lipid peroxidation (Wolfe et al,
1981). The downregulation of TR activities, as a major antioxidant
defence mechanism in HPS, would support oxidative stress.
In summary, we would like to propose that the mutated gene in
HPS on chromosome 10q23 expressing a protein with a single membrane
associated α-helix in its structure, could play an important role in
organelle-membrane function related to calcium channel integrity or
calcium ATPase activity. Further research in our laboratory is directed
toward elucidation of this interesting hypothesis.
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